Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:35 AM
Ignite Modification Date:
2025-12-25 @ 2:35 AM
NCT ID:
NCT03525834
Eligibility Criteria:
Inclusion Criteria:
* Eligible for treatment with everolimus as per the locally approved label.
* Presence of at least one AML ≥ 3 cm in its longest diameter using CT or MRI.
Exclusion Criteria:
* AML related bleeding or embolization during the 6 months prior to enrollment.
* History of myocardial infarction, angina or stroke related to atherosclerosis.
* Impaired lung function.
* Significant hematological or hepatic abnormality.
* Any severe and/or uncontrolled medical conditions.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03525834
Study Brief:
Protocol Section:
NCT03525834